How Much Does Semaglutide Cost?
Semaglutide cost is the single biggest barrier most patients face when considering GLP-1 therapy. The gap between brand-name retail pricing (over 1,000 dollars monthly) and compounded pricing (often 200 to 400 dollars monthly) is enormous. Insurance coverage varies so widely that two similar patients can pay vastly different amounts. This post covers actual pricing in 2026 across every pathway, what drives the differences, and how to figure out the cheapest legitimate option for your situation.
Brand-name Wegovy costs roughly 1,350 dollars per month at retail without insurance. Brand-name Ozempic costs about 1,000 dollars monthly. Compounded semaglutide through licensed pharmacies typically costs 200 to 400 dollars monthly. Insurance coverage can drop brand prices to 25 to 200 dollars monthly but often requires prior authorization. Your actual cost depends more on coverage than on retail pricing.
Brand-Name Semaglutide Retail Cost
Retail pricing without any insurance coverage:
- Wegovy (FDA-approved for weight loss): 1,300 to 1,400 dollars per month depending on pharmacy
- Ozempic (FDA-approved for diabetes): 950 to 1,100 dollars per month
- Rybelsus (oral semaglutide for diabetes): 900 to 1,000 dollars per month
Annual cost at retail for a year of Wegovy: roughly 16,000 dollars. This is why insurance coverage is often the deciding factor for brand-name access.
Pharmacy discount programs and manufacturer coupons can reduce retail price modestly. Novo Nordisk offers a Wegovy savings card that can reduce the copay for patients with commercial insurance, but does not help uninsured patients.
Semaglutide Cost With Insurance
Coverage varies dramatically by plan type:
Commercial insurance with weight loss coverage. Many plans now cover Wegovy under prior authorization, requiring documentation of obesity (BMI 30+) or overweight plus weight-related conditions (BMI 27+ with qualifying comorbidity). Covered copays typically range from 25 to 250 dollars monthly depending on tier placement.
Commercial insurance with diabetes coverage. Ozempic is commonly covered for type 2 diabetes. Copays typically 25 to 100 dollars monthly.
Medicare. Covers Ozempic for diabetes. Does not cover Wegovy for weight loss under current law (as of 2025). Medicare Advantage plans sometimes have different rules; check specific plans.
Medicaid. Varies significantly by state. Some states cover Wegovy for weight loss under specific criteria. Most cover Ozempic for diabetes.
No insurance. Full retail price, or compounded alternatives. Some patients qualify for Novo Nordisk’s patient assistance programs based on income.
Prior authorization is the main obstacle even for covered plans. The KFF analysis of obesity drug coverage documents that most commercial insurance plans have become more restrictive about Wegovy coverage since the initial coverage expansion in 2022-2023, citing budget impact concerns.
Compounded Semaglutide Cost
Compounded pricing varies by pharmacy and clinic but generally falls in these ranges:
- Compounded semaglutide through direct-to-consumer telehealth: 200 to 350 dollars per month, often bundled with consultation
- Compounded semaglutide through traditional clinics with compounding pharmacy partnerships: 250 to 450 dollars per month
- Compounded semaglutide through premium concierge programs: 400 to 800 dollars per month
The price differential vs brand-name comes from multiple factors: no brand premium, simpler supply chain, bulk API sourcing, and direct-to-consumer distribution models that skip pharmacy middlemen.
What the price typically includes varies by program. Some include the medication only, some include consultation and lab work, some include ongoing support. Understanding what is bundled is important for accurate comparison.
Free consultation with Dr. Ashar. Clear pricing, no surprises, multiple coverage pathways. Sugar Hill, GA and Georgia telehealth.
Book Free ConsultationHidden Costs Beyond the Medication
Monthly medication cost is often the headline number but not the total cost. Additional expenses to consider:
Initial consultation. Free at some clinics (including Tactus Health), 100 to 350 dollars at others.
Baseline labs. 150 to 400 dollars self-pay or may be insurance-covered under preventive care. Includes A1C, metabolic panel, lipid panel, thyroid function, kidney function.
Follow-up visits. Typically every 4 to 12 weeks during titration, then every 3 to 6 months on maintenance. Copays or visit fees apply.
Monitoring labs. Usually 2 to 3 times per year once stable. 100 to 300 dollars each if self-pay.
Supplies. Needles, alcohol swabs, sharps containers. 20 to 40 dollars monthly if purchased separately.
Rescue medications. Anti-nausea medication, fiber supplements, or other side effect management. 10 to 50 dollars monthly if needed.
Total first-year cost including medication and ancillary expenses:
- Uninsured on brand-name: 17,000 to 20,000 dollars
- Insured on brand-name: 1,000 to 4,000 dollars
- Uninsured on compounded: 3,500 to 6,000 dollars
- Insured with ancillary coverage: 600 to 2,500 dollars
Comparing Cost Pathways for the Same Clinical Outcome
Assume a patient needs 12 months of semaglutide therapy to achieve their weight loss goals. Cost comparison across typical pathways:
Pathway A: Uninsured, brand Wegovy at retail. 12 x 1,350 = 16,200 dollars medication + roughly 1,500 dollars ancillary = 17,700 dollars total.
Pathway B: Commercial insurance with coverage, brand Wegovy. 12 x 75 copay = 900 dollars medication + 500 dollars ancillary = 1,400 dollars total.
Pathway C: High-deductible insurance, brand Wegovy, deductible not met. 12 x 900 negotiated price = 10,800 dollars medication (until deductible met) + ancillary = 11,500 dollars total.
Pathway D: Uninsured, compounded semaglutide through telehealth. 12 x 300 = 3,600 dollars medication + minimal ancillary (often bundled) = 3,800 dollars total.
Pathway E: Insurance for labs and visits, compounded semaglutide out of pocket. 12 x 300 = 3,600 dollars medication + 200 insurance copays = 3,800 dollars total.
Pathway B (with insurance coverage) is the cheapest for patients who have it. Pathway D (compounded via telehealth) is usually the cheapest pathway for uninsured patients.
Factors That Change Your Cost
Several variables affect what you actually pay:
Geographic location. Prices vary between states and between urban vs rural pharmacies.
Pharmacy choice. GoodRx, Costco Member Pricing, and similar discount programs can reduce retail cost by 10 to 20 percent.
Dose. Lower doses (0.25, 0.5 mg starter doses) cost the same per fill as higher doses (2.4 mg maintenance dose) for brand-name products. Compounded products sometimes bill by mg of active ingredient, making lower doses somewhat cheaper.
Fill frequency. Monthly fills vs quarterly fills can affect pricing at some pharmacies.
Manufacturer promotions. Novo Nordisk has intermittent savings card offerings for commercially insured patients.
Tax-advantaged accounts. Using HSA or FSA funds for semaglutide lowers the effective cost by your marginal tax rate.
When the Cheapest Option Is Not the Best
The lowest-cost pathway is not always the right choice:
Unverified compounding sources. Saving 100 dollars monthly on an unverified product is not worth the risk of contaminated medication. Compounded semaglutide should be from licensed, accredited pharmacies with transparent sourcing.
Clinics without clinical oversight. A cheap prescription from a clinic that does not evaluate contraindications, monitor labs, or adjust dose for side effects is false economy. You will either fail therapy or have avoidable adverse events.
Skipping labs to save money. Baseline and monitoring labs catch problems early. Foregoing them to save 150 dollars can lead to thousands in emergency costs if an adverse event is missed.
The right economic frame is: cheapest legitimate pathway with appropriate clinical support. Often this is insurance-covered brand when available, or compounded with proper oversight when not.
Long-Term Cost Considerations
Semaglutide is typically a long-term therapy. Year 2 and beyond costs matter:
- Medication costs stay roughly the same if on maintenance dose
- Monitoring lab frequency often decreases (save some money)
- Follow-up visits decrease in frequency
- Insurance coverage may change year to year
- Maintenance dose is sometimes lower than peak dose (saves some money)
Patients who plan for multi-year treatment should factor in the ongoing nature of the expense. Treatment that will cost 3,500 dollars per year for five years is a different financial decision than a one-time 3,500 dollar treatment.
The FDA postmarket drug safety information for GLP-1 medications emphasizes that long-term therapy is the standard approach for chronic weight management, which affects budget planning for interested patients.
The Honest Summary
Semaglutide costs range from 200 dollars monthly (compounded) to 1,400 dollars monthly (brand-name retail uninsured). Most patients land somewhere between 50 and 400 dollars monthly depending on coverage. The main cost drivers are insurance status, brand vs compounded, and the quality of clinical oversight included. Planning for the full cost including ancillary expenses prevents surprise bills. Choosing a pathway that balances cost with proper clinical support produces the best overall value.
- Prior authorization. Insurance requirement for documentation of medical necessity before covering medication costs.
- Tier placement. Insurance formulary categorization that determines copay level. Higher tiers have higher copays.
- Negotiated price. The price insurance has agreed to pay pharmacies, which you pay if your deductible is not yet met.
- Compounded pharmacy pricing. Typically lower than brand-name due to simpler supply chain and direct-to-consumer distribution.
- Patient assistance programs. Manufacturer-run programs that provide free or reduced-cost medication to qualifying low-income patients.
Get Transparent Semaglutide Pricing
Free consultation with Dr. Ashar. Clear costs, multiple pathways, and no surprise bills. Sugar Hill, GA and Georgia telehealth.